Effects of transforming growth factor-beta 1 and fibroblast growth factor on DNA synthesis in growth plate chondrocytes are enhanced by insulin-like growth factor-I
- PMID: 8207583
- DOI: 10.1002/jor.1100120302
Effects of transforming growth factor-beta 1 and fibroblast growth factor on DNA synthesis in growth plate chondrocytes are enhanced by insulin-like growth factor-I
Abstract
The local tissue metabolism is controlled through the complex interaction between systemic and local growth factors. In recent years, an increasing number of autocrine or paracrine growth regulators have been identified in physeal cartilage. While these factors act to alter chondrocytes phenotypically and presumably are important mediators in the process of endochondral ossification, the manner in which they interact with the systemically regulated growth factor insulin-like growth factor-I is unknown. In the present study, the interactive effects of insulin-like growth factor-I with transforming growth factor-beta 1 or basic fibroblast growth factor were examined in short-term monolayer cultures of chick growth plate chondrocytes. [3H]thymidine incorporation was maximally stimulated 11-fold by fibroblast growth factor (10 ng/ml) and 3.5-fold by transforming growth factor-beta 1 following a 24-hour exposure in serum-containing cultures. The effects of transforming growth factor-beta 1 and fibroblast growth factor at both high and low concentrations were enhanced in a dose-dependent manner by insulin-like growth factor-I, with a 40-50% increase in DNA synthesis in the presence of 100 ng/ml of insulin-like growth factor-I. Since insulin-like growth factor-I increased [3H]thymidine incorporation after 48 hours (50% increase) but not after 24 hours of exposure, these observations represent a synergistic interaction. Total DNA in cultures treated for 5 days confirmed the modulating effect of insulin-like growth factor-I with transforming growth factor-beta 1 and fibroblast growth factor. The growth factors were further examined for their effects on markers of chondrocyte differentiation. While all three caused a dose-dependent inhibition of alkaline phosphatase activity, the effects of insulin-like growth factor-I were additive only to those of transforming growth factor-beta 1 and fibroblast growth factor. Similarly, insulin-like growth factor-I did not affect the sulfate incorporation stimulated by fibroblast growth factor or transforming growth factor-beta 1. Insulin-like growth factor-I had no effect on total protein synthesis after 24 hours and, although type-II collagen mRNA levels were stimulated, it had no effect on type-X collagen mRNA, as determined by quantitative in situ hybridization. Finally, insulin-like growth factor-I did not alter the dose-dependent stimulation of noncollagen protein synthesis and the inhibition of collagen synthesis caused by fibroblast growth factor and transforming growth factor-beta 1 in 24-hour cultures. Thus, the data suggest that insulin-like growth factor-I may have a role in augmenting the effects of other growth factors found in cartilage.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Differentiated cellular function in fetal chondrocytes cultured with insulin-like growth factor-I and transforming growth factor-beta.J Orthop Res. 1998 Sep;16(5):531-41. doi: 10.1002/jor.1100160503. J Orthop Res. 1998. PMID: 9820275
-
Influence of prostaglandins on DNA and matrix synthesis in growth plate chondrocytes.J Bone Miner Res. 1992 Apr;7(4):397-404. doi: 10.1002/jbmr.5650070407. J Bone Miner Res. 1992. PMID: 1319104
-
Recombinant bone morphogenetic protein (BMP)-2 regulates costochondral growth plate chondrocytes and induces expression of BMP-2 and BMP-4 in a cell maturation-dependent manner.J Orthop Res. 1997 May;15(3):371-80. doi: 10.1002/jor.1100150309. J Orthop Res. 1997. PMID: 9246083
-
Paracrinology of growth regulation.J Dev Physiol. 1991 Feb;15(2):91-104. J Dev Physiol. 1991. PMID: 1865096 Review.
-
Growth factor actions on articular cartilage.J Rheumatol Suppl. 1995 Feb;43:129-32. J Rheumatol Suppl. 1995. PMID: 7752116 Review.
Cited by
-
Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis.Knee Surg Sports Traumatol Arthrosc. 2011 Apr;19(4):528-35. doi: 10.1007/s00167-010-1238-6. Epub 2010 Aug 26. Knee Surg Sports Traumatol Arthrosc. 2011. PMID: 20740273
-
Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach.Knee Surg Sports Traumatol Arthrosc. 2012 Oct;20(10):2082-91. doi: 10.1007/s00167-011-1837-x. Epub 2011 Dec 28. Knee Surg Sports Traumatol Arthrosc. 2012. PMID: 22203046 Clinical Trial.
-
Platelet-Rich Plasma Augmentation to Microfracture Provides a Limited Benefit for the Treatment of Cartilage Lesions: A Meta-analysis.Orthop J Sports Med. 2020 Apr 21;8(4):2325967120910504. doi: 10.1177/2325967120910504. eCollection 2020 Apr. Orthop J Sports Med. 2020. PMID: 32341925 Free PMC article. Review.
-
Dose-dependent effects of combined IGF-I and TGF-beta1 application in a sheep cervical spine fusion model.Eur Spine J. 2003 Oct;12(5):464-73. doi: 10.1007/s00586-002-0483-x. Epub 2002 Nov 8. Eur Spine J. 2003. PMID: 14618385 Free PMC article.
-
Considerations for the use of platelet-rich plasma in orthopedics.Sports Med. 2014 Aug;44(8):1025-36. doi: 10.1007/s40279-014-0195-5. Sports Med. 2014. PMID: 24760591 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources